Our data show that CAR3 deficiency notably suppresses activation of Smad2/3 signaling pathway in the infarct size of cardiac tissue post-MI and in cardiac fibroblasts under TGF-β1 treatment. The gene discussed is TGFB1; the disease is myocardial infarction.